Wilmington, Del.-based ChristianaCare’s Helen F. Graham Cancer Center & Research Institute has been elected to the Association of American Cancer Institutes, joining a network of more than 100 leading academic cancer centers across North America, according to a news release shared with Becker’s.
AACI membership is granted through an evaluation of a center’s scientific programs, clinical excellence and community impact. The selection recognizes the Graham Cancer Center’s work in cancer care, research, genetics, clinical trials and community outreach.
“Our physicians, nurses, researchers and caregivers are united by a common purpose: giving every patient the best possible chance against cancer,” said Thomas Schwaab, MD, PhD, Bank of America endowed medical director of the Graham Cancer Center. “AACI membership strengthens our ability to collaborate with leading institutions, accelerate innovation and bring the latest advances in cancer care to the patients and families we serve.”
Membership gives the Graham Cancer Center greater access to multi-center research initiatives, national cancer policy discussions and collaborations in precision medicine, immunotherapy and gene editing, according to the release.
“Membership in AACI recognizes the strength of the programs we have built and the impact they have on patients,” said Nicholas Petrelli, MD, director of the Cawley Center for Translational Cancer Research. “It also creates new opportunities to advance research, expand collaborations and accelerate the translation of scientific discoveries into better treatments.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
